-8.17%07-07“Down 12% in two days with the excuse rotating from 'a Hynix research note' to 'China competition' — the reasons change daily, the stop line doesn't: $880 is the border between supercycle and stampede; play dead above it, accept fate below it, and never negotiate in between”
Score7/10Two-day slide -12.0%One-day cap loss ~$110BWSB mentions 661 (doubled again, still #1)To the $880 stop 2.7%Consensus target $1,579 (+74.6%)
Technicals — Closed at $904 below the 50-day ($924) on 1.28x volume — one notch worse than Monday's low-volume dip. RSI at 44 is nowhere near oversold, the $880 stop is one 2.7% candle away, and the May shelf at $850 waits below.
Fundamentals — A race between fundamentals and positioning: HBM sold out for 2026, pre-sold through 2027, guidance raised on 7/9 — none of that changed. What changed is the holder base: a +221% YTD profit cushion is being cashed through whichever headline serves, and China competition (the CXMT expansion story) was merely today's exit door.
News — Day two, down 8%: coverage cites China memory-competition fears plus SK Hynix/CoreWeave chain profit-taking, dragging AMD, Intel and Marvell down 5%+ together. Buffett's line — 'tough to find values when everybody is preferring gambling' on AI — got quoted everywhere.
Short-term · 1–2 weeks
LongBullish
Losing the 50-day on volume is the trend's first crack, but fundamentals (sold out, prices rising) offer no reversal evidence — so the verdict stays delegated to $880, the line written when the position opened. Mid-trade is no time to change your answer.
Entry Hold but no adds; a break of $880 means exit, and add-talk resumes only above the 50-day at $924Stop $880Target $1,100
Long-term · months+
Accumulate
HBM pricing power and 2027 revenue visibility are intact; once the holder base clears, the supercycle's next leg gets priced by fundamentals, not profit-takers.
CXMT capacity eroding non-HBM pricing mid-term
High volatility while the profit overhang clears
Escalating price competition from Korean memory makers
Signal BacktestCumulative -8.17%price itself -12.40%profitable since 07-10
07-07Long$984.75 → open → $904.28-8.17%
Community Voices
WSB · Mentions doubled again from 320 to 661, still #1 — the same crowd went from 'gift dip' to 'get out' in two days; sentiment broke before the chart didOriginal ↗
Institutional Views
华尔街共识 · 53 analysts average $1,579 — 74.6% above spot; 1.14 rating, near strong buy
24/7 Wall St · Pins the 8% drop on China-competition fears, dragging Intel, AMD and MarvellSource ↗
Motley Fool · The pullback puts the valuation back in the contested zone between 'hikes continue' and 'cycle top'Source ↗
New today“On the very day IBM cratered and memory stampeded, it rose 4% to the doorstep of an all-time high — in chaos, money isn't buying Apple's growth, it's buying Apple's certainty; 0.4% below a record there is no resistance, only vertigo, and vertigo has never been a reason to stop out”
Score7/10To the record high $328.73 — just 0.4% awayDay +4.0% on 1.24x volumeWSB mentions 68 (5.7x)RSI(14) 68.8Consensus target $318.76 (now below spot)
Technicals — Up 4% on volume to $327.50, one step from the $328.73 record. The 20- and 50-day averages sit far below at $302/$300, and RSI at 68.8 is warm but not redlined — a volume-confirmed breakout opens airless territory above.
Fundamentals — Safe-harbor logic on hardware-collapse day: the certainty trio of cash flow, buybacks and ecosystem lock-in got panic-bought after IBM's warning, while the OpenAI trade-secrets suit backhandedly certifies the hardware moat's worth. The consensus target now trails the price — analysts are chasing it upward.
News — A strength day without a press release: money fleeing fallen IBM and the memory chain crowded into megacap certainty (Microsoft +2.8%, Alphabet +3.2%), with Apple leading at +4% and WSB mentions up nearly 6x.
Short-term · 1–3 weeks
LongBullish
Three tailwinds: haven flows, a record-high structure and consensus playing catch-up. The $308 stop sits in the buffer above the 20/50-day cluster, a full 2.3 ATRs away.
Entry Hold; a volume break of $328.73 followed by a holding retest is the add-watch, with the $315 shelf as pullback supportStop $308Target $350
Long-term · months+
Accumulate
Ecosystem cash flows, services growth and the on-device AI option; the certainty premium still has room to re-rate in a messy tape.
The certainty premium cuts both ways if growth disappoints
China demand and geopolitical noise
On-device AI shipping slower than hoped
Community Voices
WSB · Mentions 12→68 as the old 'buy before or after the record' debate reopens — the answer was always sizing, never timingOriginal ↗
Institutional Views
华尔街共识 · 52 analysts average $318.76 — now 2.7% below spot; the price is ahead of consensus and the upgrade cycle is under way
New today“The season's opening shot printed 86% equities-trading growth — volatility is retail's cost and the house's revenue, and everyone's panic this quarter got booked into JPMorgan's P&L; a mere 1.2% post-earnings gain isn't disbelief, it's big money taking its seat slowly”
Score7/10Q2 scorecard EPS $6.14 vs $5.85 est; revenue $58B, a huge beatEquities trading +86% to $6BSector echo MS profit +58%, BlackRock +6.6%, BNY raised guidanceTo 52-wk high -1.2%RSI(14) 67.5
Technicals — Up 1.2% the day after earnings to $346.91, one step from the $351.24 high. The rising 20-day at $334 now acts as support, RSI 67.5 is strong without redlining, and the sector (XLF +0.7%, KBWB +1.5%) escorts it at collective records.
Fundamentals — Q2 steamrolled: EPS of $6.14 on $58B revenue with record equities trading (+86%); IB fees rode the SpaceX IPO wave; and Dimon called the US economy 'notably resilient' on the AI-capex, fiscal and deregulation engines. It's a double hit of volatility dividend plus reopened capital markets.
News — All five megabanks reported premarket on 7/14 with JPMorgan leading the sweep; 7/15 added Morgan Stanley's +58% profit, BlackRock's $6B quarterly private-debt haul and BNY lifting full-year revenue guidance to +10–11% — an industry-wide harvest from the trading-plus-IB twin engines.
Short-term · 1–3 weeks
LongBullish
Earnings confirmation, sector resonance and rising consensus stack up; the $326 stop sits an ATR under the 20-day. With event risk released, this is the cheapest stretch of the trend to hold.
Entry Hold; a 20-day retest at $334 is the add-watch, and a break of the $351 record opens $365Stop $326Target $365
Long-term · months+
Accumulate
Scale plus the universal-banking franchise compounds through high-vol, high-rate regimes; the biggest beneficiary of a reopened capital-markets cycle.
Provision pressure if the credit cycle sours
Trading revenue's high base is hard to lap
Regulatory pendulum swings
Institutional Views
华尔街共识 · 27 analysts average $365.36 — 5.3% above spot; consensus is still catching up to the print
CNBC · A double beat with the 86% equities-trading surge as the headlineSource ↗
-6.03%07-07“Three days pinned 1.1% above the stop — the market has nailed it to the knife's edge before earnings. A stock with a $17.70 ATR sitting $4.50 from $390 no longer answers to fundamentals; it answers to whichever day the tape sneezes. Four sessions left on a discipline position — don't improvise”
Score6/10To the $390 stop 1.1%Earnings countdown 7/22 — four sessions awayThis week -1.2%, pinned under the 20-dayATR $17.7Consensus target $407 (+3.3%)
Technicals — Down 0.4% to $394.46, a third straight session hugging the $390 stop. The 20-day ($399) and 50-day ($410) press from above on 0.77x volume — both sides are waiting for 7/22, and neither will show its hand early.
Fundamentals — The 480k-delivery card (+25%) is priced; the only suspense on 7/22 is margin — whether volume was bought with cuts and financing subsidies. Flat EPS consensus at $0.27 makes the low bar itself the biggest variable of the day.
News — A newsless waiting room. After the IBM episode, tolerance for full-size positions into earnings has dropped visibly, and the high-ATR-plus-imminent-event combination is being systematically de-risked.
Short-term · Into 7/22 earnings
LongBullish
The original discipline stands, but event risk got a heavier weight: with the stop in its face and earnings imminent, choosing 'trim first' over 'wait for the stop' is exactly what this week's tuition paid for.
Entry Hold without adds; a $390 break means exit. The IBM lesson applies: if it's still hugging the line at Monday's close, halve the position before the printStop $390Target $430
Long-term · months+
Neutral
The robotaxi/FSD and storage curves are real but heavily pre-priced; no new chips before the 7/22 margin answer.
Margin miss
Q3 sequential pressure off the delivery high base
Brand noise from political exposure
Signal BacktestCumulative -6.03%price itself -7.25%
07-07Long$419.77 → open → $394.46-6.03%
Institutional Views
华尔街共识 · 51 analysts average $407 — 3.3% above spot at a 1.77 rating; consensus is fully priced with the dispute parked on margin
+9.07%07-04“Memory cratered 12% in two days while it climbed 8.9% on the week — when the ammo plants blow up and the arms dealer still raises prices, that's what pricing power looks like. The gap between its weekly chart and the memory chain is this year's cleanest relative-strength signal; above $205, don't outsmart yourself”
Score7/10Week +8.9% (while the memory chain cratered)Day +0.3% on a day memory fell 8%Above both averages 20-day $202 / 50-day $210To 52-wk high -10.2%Consensus target $314 (+47.6%)
Technicals — Up 0.3% to $212.50, back above the 50-day ($210) with the +8.9% week scissoring away from memory. RSI 56.9 is healthy on 0.92x volume; the $215–220 June congestion sits overhead, and clearing it targets the $236 prior high.
Fundamentals — The memory panic is a cost-side tailwind — HBM is a purchase line, not a revenue line. The real tells are TSMC's rumored price hikes and ASML holding firm through earnings week: upstream capacity is queuing for its next platform. Order visibility remains the market's best.
News — No company news; the divergence day (AMD -3.5%, Marvell -7.3% vs NVDA +0.3%) confirms money rotating within the compute chain — long the strong, cut the weak.
Short-term · 1–3 weeks
LongBullish
With relative strength confirmed and both averages reclaimed, the old stop is too far away; raising it to $205 locks the floor under this leg's gains — a trend position's stop only ever moves up.
Entry Hold with the stop raised from $196 to $205 (above the 20-day); a $208–210 retest is the re-entry windowStop $205Target $236
Long-term · months+
Accumulate
The full-stack arms dealer of the AI compute race with deepening platform lock-in; upstream price hikes only entrench its pricing power.
HBM supply bottlenecks pacing shipments
Hyperscaler in-house silicon diverting spend
Export-control escalation
Signal BacktestCumulative +9.07%price itself +7.55%profitable since 07-07
07-04Long$194.83 → open → $212.5+9.07%
Community Voices
WSB · 121 mentions holds a top-10 slot; the most common line in memory-crash threads is 'so where did the money go' — its weekly chart is the answerOriginal ↗
Institutional Views
华尔街共识 · 66 analysts average $314 — 47.6% above spot; 1.14 rating, near strong buy
+4.78%07-14“One day after entry it kicked the HK$130 door open and printed a 138.70 record for good measure — this is the sweetest stretch of any breakout trade, but with RSI at 70 and targets at spot, the move is to raise the stop and lock in dignity, not to double the bet at the high”
Score7/10Breakout confirmed Cleared the HK$130 prior high; new 52-wk high HK$138.70Since entry 7/14 at HK$127.60 → +4.8%Week / month +20.1% / +42.2%RSI(14) 69.9Bank target avg HK$136.0
Technicals — Flat at HK$133.70 this morning after yesterday's push to a record HK$138.70. The MA stack is fully bullish (20-day at HK$112.69) and the cleared HK$130 now flips to support; RSI at 69.9 is borderline, with volume confirmation pending this afternoon's session.
Fundamentals — The CXO duo keeps resonating — WuXi Bio (2269, held) printed another high the same day. The warming peptide/small-molecule order cycle and interim-report visibility remain the spine, and the RMB-1 H-share incentive still aligns management.
News — No fresh filings; the HK$136 average bank target has been caught by the price — the CXO sector is now testing the earnings-drive-targets-higher loop, with interims as the next catalyst.
Short-term · 1–3 weeks
LongLean bullish
With the breakout confirmed, trailing the stop is the entire management plan: no adds in the RSI-70 zone, HK$150 as the measured-move target, and a break of HK$122 would brand it a failed breakout — take the loss and go.
Entry Hold with the stop raised from HK$115 to HK$122 (an ATR under the cleared 130); a holding retest of HK$128–131 is healthy confirmationStop HK$122Target HK$150
Long-term · months+
Accumulate
A warming CXO cycle with peptide (GLP-1 spillover) order torque and utilization-driven operating leverage; incentives align management.
Geopolitical (Biosecure-style) risk resurfacing
Order-cycle volatility
Near-term pullback risk from overbought levels
Signal BacktestCumulative +4.78%price itself +4.78%profitable since 07-16
07-14LongHK$127.6 → open → HK$133.7+4.78%
Community Voices
雪球 · Post-record comments split between profit screenshots and bubble calls — in breakouts, the screenshot crowd always exits before the top-callers; it's traditionOriginal ↗
Institutional Views
华尔街共识 · 8 analysts average HK$135.96 — 1.7% above spot; the breakout has caught the targets, and the pressure to raise now sits with the analysts
+16.17%07-02“Up 19.9% in a week and parked to the penny against the 50-day — it's rare courtesy for the market to write the exam question this neatly: clear the line and the re-rating opens chapter two, fail it and you have the sketch of a double top; stop raised to HK$108, let the answer reveal itself”
Score8/10Week +19.9%Key level Pressing the 50-day at exactly HK$116.20Position P&L ~+16% since inclusionRSI(14) 62.7Consensus target HK$185 (+59.3%)
Technicals — Up 2.5% this morning to HK$116.20, dead level with the 50-day. RSI 62.7 is healthy with the 20-day far below at HK$102; the overhead gap and HK$120 round number form the second test, with volume telling this afternoon.
Fundamentals — The ~45% cloud-growth preview and the Qwen 4.0 productivity-suite story keep fermenting; the banks' 'reprice AI assets' thesis remains the fuel layer, with the late-August report as the next checkpoint.
News — No fresh news; against an empty HK screener morning it led the book with +2.5%, and the +19.9% week is the portfolio's strongest momentum.
Short-term · 1–3 weeks
LongBullish
The strongest momentum in the book earns the tightest trailing stop; three failed attempts at the 50-day would mean fading thrust, at which point protecting gains outranks chasing targets.
Entry Hold with the stop raised from HK$105 to HK$108; a volume move through the 50-day and HK$120, then a holding retest, is the add-watchStop HK$108Target HK$130
Long-term · months+
Accumulate
Early innings of the cloud+AI re-rating at a discount to US peers, with commerce cash flow funding the capex cycle.
LLM monetization underdelivering
Technical rejection at the 50-day/HK$120 double gate
Weak consumption recovery
Signal BacktestCumulative +16.17%price itself +23.49%0/1 closed trades wonprofitable since 07-09
07-02LongHK$94.5 → closed HK$94.107-04-0.42%
07-08LongHK$99.6 → open → HK$116.2+16.67%
Community Voices
雪球 · 'Does it clear the 50-day' is the pinned debate — chartists and fundamentalists rarely stare at the same line, and that shared gaze amplifies whichever break comesOriginal ↗
Down 3.5% to $529.14 in the memory sympathy hit, 2.1% above the $518 stop — trailing NVIDIA by a full length is getting conspicuous; a break means exit
Up 0.8% this morning at HK$478.00, the +3.6% week putting 6% between price and stop — last week's line-hugging agony bought this week's calm; stop raised to HK$460, holding
Flat this morning at HK$97.00, one step from the round number — RSI 72 runs hot but the innovative-drug theme is +24.4% on the month; stop raised to HK$88, holding
